Evidence map›Paper›PMID 30471381›Full record

ArticleToxicon : official journal of the International Society on Toxinology2019

The analgesic effect of intraarticular OnabotulinumtoxinA in a female murine model of collagenase induced chronic degenerative monoarthritis.

Nicole Blanshan, Maren L Mahowald, Christopher Dorman, Sandra Frizelle, Hollis E Krug

Open access · hybridAbstract read
In one paragraph

Article in Toxicon : official journal of the International Society on Toxinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nicole BlanshanRheumatology Department, Veterans Affairs Medical Center, Minneapolis, MN, United States. Electronic address: nicole.blanshan@va.gov.
Maren L MahowaldRheumatology Department, Veterans Affairs Medical Center, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States. Electronic address: mahow001@gmail.com.
Christopher DormanRheumatology Department, Veterans Affairs Medical Center, Minneapolis, MN, United States. Electronic address: christopher.dorman@va.gov.
Sandra FrizelleRheumatology Department, Veterans Affairs Medical Center, Minneapolis, MN, United States. Electronic address: sandra.frizelle@va.gov.
Hollis E KrugRheumatology Department, Veterans Affairs Medical Center, Minneapolis, MN, United States; Department of Medicine, University of Minnesota, Minneapolis, MN, United States. Electronic address: hollis.krug@va.gov.
Veterans Health Administration · USUniversity of Minnesota · US

Funding

Effect of Articular Neurotoxin on Joint Pain and Neurochemical SignatureI01RX000379 · VA · MINNEAPOLIS VA MEDICAL CENTER · PI KRUG, HOLLIS ELAINE, MAHOWALD, MAREN LAWSON · 2012 to 2022
–
RRD VA I01 RX000379
6 · The paper itself

Abstract

purposeWe previously reported the efficacy of intraarticular (IA) rimabotulinumtoxinB (BoNT/B) in a murine model of chronic degenerative arthritis pain. This study aimed to measure the analgesic effects of onabotulinumtoxinA (BoNT/A) on collagenase induced chronic degenerative arthritis joint pain.

methodsChronic degenerative arthritis was produced by IA injection of 10 μl collagenase (Col) (10 IU) into the left knee of C57BL/6J female mice 4 weeks prior to pain assessment. IA BoNT/A was injected 3 days before testing. Arthritis pain was measured as evoked pain scores (EPS) and spontaneous pain behaviors with an advanced dynamic weight bearing (ADWB) device. EPS was a tally of fights and vocalizations exhibited in one minute with knee palpation. Percent body weight and percent time spent on each limb was quantified. All mice were 12 weeks old at the time of examination.

resultsIA Col increased EPS and reduced ADWB measures of percent weight bearing on the left hind limb compared to naïve mice. BoNT/A treatment reduced EPS and increased weight bearing on the left hind limb. The improvements were not significant compared to the Col group. There was no significant difference in time spent on the left hind limb between any treatment groups. Forelimb ADWB measures of percent weight and time in arthritic mice significantly increased compared to nonarthritic animals. Treatment with BoNT/A in the arthritic limb decreased this offloading; however, statistical analysis only showed significance in weightbearing.

conclusionIA Col monoarthritis increased evoked and spontaneous pain behaviors in female mice after four weeks. Treatment with IA BoNT/A decreased pain behaviors but only forelimb weight bearing showed a significant improvement. This led us to conclude that treatment with BoNT/A is not an effective analgesic for the treatment of chronic degenerative knee arthritis in murine models.

Indexed as

AnalgesicsAnimalsArthritis, ExperimentalBotulinum Toxins, Type ACollagenasesDisease Models, AnimalFemaleHindlimbInjections, Intra-ArticularMice, Inbred C57BLPain MeasurementWeight-BearingAnalgesicsBotulinum Toxins, Type ACollagenasesincobotulinumtoxinABotox™MouseNeurotoxinsOsteoarthritisPain

Identifiers

PMID30471381
PMCPMC7291841
OpenAlexW2900965614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.